Davis Polk – Rally Software Initial Public Offering

Davis Polk advised the underwriters in connection with an initial public offering of 6,900,000 shares of common stock of Rally Software Development Corp. (including 900,000 shares in respect of the exercise in full of the underwriters’ option to purchase additional shares) at $14.00 per share for gross proceeds of $96.6 million. Deutsche Bank Securities Inc. and Piper Jaffray & Co. acted as lead book-running managers and Needham & Company, LLC, JMP Securities LLC and William Blair & Company, L.L.C. acted as co-managers. Rally Software’s common stock is traded on the New York Stock Exchange under the symbol “RALY.”

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley

Ogletree Deakins Opens 44th Office

Ogletree, Deakins, Nash, Smoak & Stewart, P.C. (Ogletree Deakins), one of the largest labor and employment law firms representing management, is pleased to announce the opening of its Richmond, Virginia office. The office opens Thursday with two shareholders and an of counsel. Future growth in the Richmond office is expected soon. Jimmy F. Robinson, Jr., who joins Ogletree Deakins from Troutman Sanders, will serve as the office’s managing shareholder. Elizabeth Ebanks, formerly a partner at LeClairRyan, joins as shareholder, and Tevis Marshall, formerly a senior associate at Troutman Sanders, joins as of counsel. Ogletree Deakins continues its dramatic growth in response to client demand as Richmond is the second office the firm has opened in 2013 and the fifth to open in the past year. The firm opened its San Diego office in January and offices in Berlin, Germany, New York City, and Stamford, Connecticut in 2012.

More >>

Tags:  Ogletree Deakins

Davis Polk – Synergy Pharmaceuticals Inc. Common Stock Offering

Davis Polk advised Credit Suisse Securities (USA) LLC, Citigroup Global Markets Inc. and Canaccord Genuity Inc. as joint book-running managers and representatives of the underwriters of an approximately $90 million SEC-registered offering of 16,375,000 shares of common stock of Synergy Pharmaceuticals Inc. Cantor Fitzgerald & Co. acted as co-manager of the offering. The common stock is listed on the Nasdaq Global Market under the symbol “SGYP.”

More >>

Tags:  Davis Polk & Wardwell LLP | New York